Comparison of the disposition of butadiene epoxides in Sprague-Dawley rats and B6C3F1 mice following a single and repeated exposures to 1,3-butadiene via inhalation

Toxicology

Volumn 123, Issue 1-2, 1997, Pages 125-134

  Thornton Manning, Janice R ^a,b   Dahl, Alan R ^a   Bechtold, William E ^a   Griffith Jr , William C ^a,c   Henderson, Rogene F ^a  

^a Lovelace Biomedical and Environmental Research Institute   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

1,3 Butadiene; Butadiene diepoxide; Butadiene monoepoxide; Metabolism

Indexed keywords

1,3 BUTADIENE; BUTADIENE DIEPOXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INHALATION; MALE; METABOLITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ADIPOSE TISSUE; ADMINISTRATION, INHALATION; ANIMALS; BUTADIENES; CARCINOGENS; EPOXY COMPOUNDS; FEMALE; FEMUR; LUNG; MAMMARY GLANDS, ANIMAL; MICE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RODENTIA;

EID: 0030756760     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(97)00112-1     Document Type: Article

References (35)

1. Bechtold, W.E., Strunk, M.R., Thornton-Manning, J.R., Henderson, R.F., 1995. Analysis of butadiene, butadiene monoxide and butadiene dioxide in blood by gas chromatography/gas chromatography/mass spectroscopy. Chem. Res. Toxicol. 8, 182-187.
2. Bolt, H.M., Schmiedel, G., Filser, J.G., Rolzhauser, H.P., Lieser, K., Wistuba, D., Schurig, V., 1983. Biological activation of 1,3-butadiene to vinyl oxirane by rat liver microsomes and expiration of the reactive metabolite by exposed rats. J. Cancer Res. Clin. Oncol. 106, 112-116.
3. Bonate, P.L., 1991. Gender-related differences in xenobiotic metabolism. J. Clin. Pharmacol. 31, 684-690.
4. Bond, J.A., Dahl, A.R., Henderson, R.F., Dutcher, J.S., Mauderly, J.L., Birnbaum, L.S., 1986. Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 84, 617-627.
5. Bond, J.A., Martin, O.S., Birnbaum, L.S., Dahl, A.R., Melnick, R.L., Henderson, R.F., 1988. Metabolism of 1,3-butadiene by lung and liver microsomes of rats and mice repeatedly exposed by inhalation to 1,3-butadiene. Toxicol. Lett. 44, 143-151.
6. Bond, J.A., Recio, L., Andjelkovich, D., 1995. Epidemiological and mechanistic data suggest that 1,3-butadiene will not be carcinogenic to humans at exposures likely to be encountered in the environment or workplace. Carcinogenesis 16, 165-171.
7. Boogaard, P.J., Sumner, S.C.J., Bond, J.A., 1996. Glutathione conjugation of 1,2:3,4-diepoxybutane in human liver and rat and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 136, 307-316.
8. Chemical and Engineering News, 1994. Top 50 chemical production rose modestly last year. Chemical Engineering News, April 11, 12-16.
9. Chemical and Engineering News, 1995. Production of top 50 chemicals increased substantially in 1994. Chemical Engineering News, April 10, 16-20.
10. Cochrane, J.E., Skopek, T.R., 1994. Mutagenicity of butadiene and its epoxide metabolites: I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 15, 713-714.
11. Csanády, G.A., Guengerich, F.P., Bond, J.A., 1992. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
12. Dahl, A.R., Benson, J.M., Hanson, R.L., Rothenberg, S.J., 1984. The fractionation of environmental samples according to volatility by vacuum line-cryogenic distillation. Am. Ind. Hyg. Assoc. J. 45, 193-198.
13. Dahl, A.R., Sun, J.D., Birnbaum, L.S., Bond, J.A., Griffith, W.C., Mauderly, J.L., Muggenburg, B.A., Sabourin, P.J., Henderson, R.F., 1991. Toxicokinetics of inhaled 1,3-butadiene in monkeys: Comparison to toxicokinetics in rats and mice. Toxicol. Appl. Pharmacol. 110, 9-19.
14. Deuscher, R.J., Elfarra, A.A., 1993. Chloroperoxidase-mediated oxidation of 1,3-butadiene to 3-butenal, a crotonaldehyde precursor. Chem. Res. Toxicol. 6, 669-673.
15. Duescher, R.J., Elfarra, A.A., 1994. Human liver microsomes are efficient catalysts of 1,3-butadiene oxidation: Evidence of major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342-349.
16. Environmental Protection Agency, 1991. Preliminary draft list of categories and sub-categories under 112 section of the Clean Air Act. Federal Regulation 56, 28 548-28 557.
17. Fajen, J.M., Roberts, D.R., Ungers, L.J., Krishnan, E.R., 1990. Occupational exposure of workers to 1,3-butadiene. Environ. Health Perspect. 86, 11-18.
18. Gonzalez, F.J., 1992. Human cytochromes P450: Problems and prospects. Trends Pharmacol. Sci. 13, 346-352.
19. Himmelstein, M.W., Turner, M.J., Asgharian, B., Bond, J.A., 1994. Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15, 1479-1486.
20. Himmelstein, M.W., Asgharian, B., Bond, J.A., 1995. High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol. 132, 281-288.
21. 1 mice after 60 weeks of inhalation exposure. Science 277, 548-549.
22. Malvoisin, E., Roberfroid, M., 1982. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 12, 137-144.
23. Maples, K.R., Lane, J.L., Dahl, A.R., 1992. An efficient method for synthesizing [d6]-butadiene monoepoxide. J. Labelled Compounds Radiopharm. 31, 469-475.
24. Melnick, R.L., Huff, J., Chou, B.J., Miller, R.A., 1990. Carcinogenicity of 1,3-butadiene in C57BL/6 X C3H F1 mice at low exposure concentrations. Cancer Res. 50, 6592-6599.
25. Miller, L.M., 1978. Investigation of selected potential environmental contaminants: Butadiene and its oligomers. EPA 560/2-78-008.
26. Owen, P.E., Glaister, J.R., Gaunt, I.F., Pullinger, D.H., 1987. Inhalation toxicity studies with 1,3-butadiene: 3 two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 48, 407-413.
27. Poncelet, F., deMeester, C., Duverger-van Bogaert, M., Lambotte-Vandepaer, M., Roberfroid, M., Mercier, M., 1980. Influence of experimental factors on the mutagenicity of vinylic monomers. Arch. Toxicol. 4, 63-66.
28. Raabe, O.G., Bennick, J.E., Light, M.E., Hobbs, C.H., Thomas, R.L., Tillery, M.I., 1973. An improved apparatus for acute inhalation exposure of rodents to radioactive aerosols. Toxicol. Appl. Pharmacol. 26, 264-273.
29. Ronis, M.J.J., Badger, T.M., Thomas, P.E., Hakkak, R., 1994. Cytochrome P450-dependent metabolism of steroids and xenobiotics in adipose tissue: P450 isozyme occurrence, sexual dimorphism and regulation. ISSX Proc. 6, 163.
30. Schmidt, U., Loeser, E., 1985. Species differences in the formation of butadiene monoxide from 1,3-butadiene. Arch. Toxicol. 57, 222-225.
31. Seaton, M.J., Follansbee, M.H., Bond, J.A., 1995. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16, 2287-2293.
32. Sweeney, L.M., Schlosser, P.M., Medinsky, M.A., Bond, J.A., 1997. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats. Carcinogenesis 18 (4), 611-625.
33. Thornton-Manning, J.R., Dahl, A.R., Bechtold, W.E., Griffith, W.C. Jr., Henderson, R.F., 1995a. Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.
34. Thornton-Manning, J.R., Dahl, A.R., Bechtold, W.E., Griffith, W.C. Jr., Pei, L., Henderson, R.F., 1995b. Gender differences in the metabolism of 1,3-butadiene in Sprague-Dawley rats following a low level inhalation exposure. Carcinogenesis 16, 2875-2878.
35. Voogd, C.E., van der Stel, J.J., Jacobs, J.J.J.A.A., 1981. The mutagenic action of aliphatic epoxides. Mutat. Res. 89, 269-282.